CD4+CD25+ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge (original) (raw)
Waldmann TA . Effective cancer therapy through immunomodulation. Annu Rev Med 2006; 57: 65–81. ArticleCASPubMed Google Scholar
Sakaguchi S . Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531–562. ArticleCASPubMed Google Scholar
Antony PA, Piccirillo CA, Akpinarli A, Finkelstein SE, Speiss PJ, Surman DR et al. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol 2005; 174: 2591–2601. ArticleCASPubMed Google Scholar
McHugh RS, Shevach EM . Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 2002; 168: 5979–5983. ArticleCASPubMed Google Scholar
Casares N, Arribillaga L, Sarobe P, Dotor J, Lopez-Diaz de Cerio A, Melero I et al. CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination. J Immunol 2003; 171: 5931–5939. ArticleCASPubMed Google Scholar
Kohm AP, McMahon JS, Podojil JR, Begolka WS, DeGutes M, Kasprowicz DJ et al. Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J Immunol 2006; 176: 3301–3305. ArticleCASPubMed Google Scholar
Mennuni C, Calvaruso F, Facciabene A, Aurisicchio L, Storto M, Scarselli E et al. Efficient induction of T-cell responses to carcinoembryonic antigen by a heterologous prime-boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNA. Int J Cancer 2005; 17: 444–455. Article Google Scholar
Facciabene A, Aurisicchio L, La Monica N . Baculovirus vectors elicit antigen-specific immune responses in mice. J Virol 2004; 78: 8663–8672. ArticleCASPubMedPubMed Central Google Scholar
Clarke P, Mann J, Simpson JF, Rickard-Dickson K, Primus FJ . Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy. Cancer Res 1998; 58: 1469–1477. CASPubMed Google Scholar
Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A . Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708–712. ArticleCASPubMed Google Scholar
Kaech SM, Hemby S, Kersh E, Ahmed R . Molecular and functional profiling of memory CD8T cell differentiation. Cell 2002; 111: 837–851. ArticleCASPubMed Google Scholar
Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE et al. Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci USA 2005; 102: 9571–9576. ArticleCASPubMedPubMed Central Google Scholar
Youil R, Toner TJ, Su Q, Chen M, Tang A, Bett AJ et al. Hexon gene switch strategy for the generation of chimeric recombinant adenovirus. Hum Gene Ther 2002; 13: 311–320. ArticleCASPubMed Google Scholar
Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J . Vaccine therapy of established tumors in the absence of autoimmunity. Clin Cancer Res 2003; 9: 1837–1849. CASPubMed Google Scholar
Golgher D, Jones E, Powrie F, Elliott T, Gallimore A . Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur J Immunol 2002; 32: 3267–3275. ArticleCASPubMed Google Scholar
Facciabene A, Aurisicchio L, Elia L, Palombo F, Mennuni C, Ciliberto G et al. DNA and adenoviral vectors encoding carcinoembryonic antigen fused to immunoenhancing sequences augment antigen-specific immune response and confer tumor protection. Hum Gene Ther 2006; 17: 81–92. ArticleCASPubMed Google Scholar
Zhou H, Luo Y, Mizutani M, Mizutani N, Becker JC, Primus FJ et al. A novel transgenic mouse model for immunological evaluation of carcinoembryonic antigen-based DNA minigene vaccines. J Clin Invest 2004; 113: 1792–1798. ArticleCASPubMedPubMed Central Google Scholar
Kass E, Schlom J, Thompson J, Guadagni F, Graziano P, Greiner JW . Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus. Cancer Res 1999; 59: 676–683. CASPubMed Google Scholar
Bos R, van Duikeren S, van Hall T, Kaaijk P, Taubert R, Kyewski B et al. Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoire. Cancer Res 2005; 65: 6443–6449. ArticleCASPubMed Google Scholar
Tanaka H, Tanaka J, Kjaergaard J, Shu S . Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes. J Immunother 2002; 25: 207–217. ArticleCASPubMed Google Scholar
Shimizu J, Yamazaki S, Sakaguchi S . Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999; 163: 5211–5218. CASPubMed Google Scholar
Jones E, Dahm-Vicker M, Simon AK, Green A, Powrie F, Cerundolo V et al. Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Immun 2002; 2: 1. PubMed Google Scholar
Tawara I, Take Y, Uenaka A, Noguchi Y, Nakayama E . Sequential involvement of two distinct CD4+ regulatory T cells during the course of transplantable tumor growth and protection from 3-methylcholanthrene-induced tumorigenesis by CD25-depletion. Jpn J Cancer Res 2002; 93: 911–916. ArticleCASPubMedPubMed Central Google Scholar
Kudo-Saito C, Schlom J, Camphausen K, Coleman CN, Hodge JW . The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors. Clin Cancer Res 2005; 11: 4533–4544. ArticleCASPubMed Google Scholar
Toka FN, Suvas S, Rouse BT . CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. J Virol 2004; 78: 13082–13089. ArticleCASPubMedPubMed Central Google Scholar
Kursar M, Bonhagen K, Fensterle J, Kohler A, Hurwitz R, Kamradt T et al. Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses. J Exp Med 2002; 196: 1585–1592. ArticleCASPubMedPubMed Central Google Scholar
Sakaguchi S, Takahashi T, Yamazaki S, Kuniyasu Y, Itoh M, Sakaguchi N et al. Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: implications for autoimmunity and tumor immunity. Microbes Infect 2001; 3: 911–918. ArticleCASPubMed Google Scholar
Wei WZ, Jacob JB, Zielinski JF, Flynn JC, Shim KD, Alsharabi G et al. Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice. Cancer Res 2005; 65: 8471–8478. ArticleCASPubMed Google Scholar
Dannull J, Su Z, Rizzieri D, Yang BK, Coleman D, Yancey D et al. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest 2005; 115: 3623–3633. ArticleCASPubMedPubMed Central Google Scholar